Polls and policy: Signals or substance

Journal of Clinical Oncology

Volumn 33, Issue 8, 2015, Pages 819-820

  Howie, Lynn J ^a   Peppercorn, Jeffrey M ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CENTER; CANCER RESEARCH; CANCER SURVIVAL; CANCER THERAPY; COMPARATIVE EFFECTIVENESS; CONSENSUS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; EDITORIAL; FINANCIAL MANAGEMENT; GROSS NATIONAL PRODUCT; HEALTH CARE; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; MEDICARE; NATIONAL HEALTH SERVICE; OVERALL SURVIVAL; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; PROGRESSION FREE SURVIVAL; PUBLIC HEALTH INSURANCE; REIMBURSEMENT; ECONOMICS; FEMALE; MALE; PHYSICIAN; PUBLIC OPINION;

FEMALE; HUMANS; MALE; MEDICARE; PHYSICIANS; PUBLIC OPINION;

EID: 84924912470     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.59.8524     Document Type: Editorial

References (18)

1. Mariotto AB, Yabroff KR, Shao Y, et al: Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 103:117-128, 2011
2. Ramsey S, Blough D, Kirchhoff A, et al: Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood) 32:1143-1152, 2013
3. Zafar SY, Peppercorn JM, Schrag D, et al: The financial toxicity of cancer treatment: A pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist 18:381-390, 2013
4. Oberlander J: Unfinished journey: A century of health care reform in the United States. N Engl J Med 367:585-590, 2012
5. Peppercorn J, Zafar SY, Houck K, et al: Does comparative effectiveness research promote rationing of cancer care? Lancet Oncol 15:e132-e138, 2014
6. Blendon RJ, Altman DE: Public attitudes about health-care costs: A lesson in national schizophrenia. N Engl J Med 311:613-616, 1984
7. Meropol NJ, Schulman KA: Cost of cancer care: Issues and implications. J Clin Oncol 25:180-186, 2007
8. Sullivan R, Peppercorn J, Sikora K, et al: Delivering affordable cancer care in high-income countries. Lancet Oncol 12:933-980, 2011
9. Neumann PJ, Chambers JD: Medicare's enduring struggle to define "reasonable and necessary" care. N Engl J Med 367:1775-1777, 2012
10. Gogineni K, Shuman K, Chinn D, et al: Making cuts to Medicare: The views of patients, physicians, and the public. J Clin Oncol 33:846-853, 2015
11. Schnipper LE, Lyman GH, Blayney DW, et al: American Society of Clinical Oncology 2013 top five list in oncology. J Clin Oncol 31:4362-4370, 2013
12. Bach PB: Limits on Medicare's ability to control rising spending on cancer drugs. N Engl J Med 360:626-633, 2009
13. Ilene Hays v Kathleen Sebelius, Secretary of the US Department of Health and Human Services, et al, 2009
14. Ray N, Smalley K: Developing payment policy to promote use of services based on clinical evidence. http://www.medpac.gov/documents/november-2014-meeting-presentation-developing-payment-policy-to-promote-the-use-of-services-based-on-clinical-evidence.pdf?sfvrsn=0
15. Thomas K, Pear R: Plan to limit some drugs in Medicare is criticized. New York Times, February 22, 2014:B1
16. Blendon RJ, Benson JM: The public's views about Medicare and the budget deficit. N Engl J Med 365:e8, 2011
17. Irwin B, Kimmick G, Altomare I, et al: Patient experience and attitudes toward addressing the cost of breast cancer care. Oncologist 19:1135-1140, 2014
18. Blendon RJ, Benson JM: The public and the conflict over future Medicare spending. N Engl J Med 369:1066-1073, 2013